Metabolites that were altered in iNOS-/- mice, correlated strongly with dyslipidemia, IR and glucose intolerance and most of them including the bacterial-derived metabolites were rescued by the treatment with ampicillin-neomycin combination. This evidence concerns the gene NOS2 and Glucose intolerance.